Patents by Inventor David F. Mahoney

David F. Mahoney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A82846 antibiotics
    Patent number: 5843437
    Abstract: New glycopeptide antibiotic A82846, comprising A82846A, A82846B and A82846C, is produced by Nocardia orientalis strains NRRL 18098, NRRL 18099 and NRRL 18100. The A82846 antibiotics have activity against Gram-positive bacteria comparable to that of vancomycin.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 1, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robert L. Hamill, James A. Mabe, David F. Mahoney, Walter M. Nakatsukasa, Raymond C. Yao
  • A82846 antibiotics
    Patent number: 5312738
    Abstract: New glycopeptide antibiotic A82846, comprising A82846A, A82846B and A82846C, is produced by Nocardia orientalis strains NRRL 18098, NRRL 18099 and NRRL 18100. The A82846 antibiotics have activity against Gram-positive bacteria comparable to that of vancomycin.
    Type: Grant
    Filed: May 9, 1990
    Date of Patent: May 17, 1994
    Assignee: Eli Lilly and Company
    Inventors: Robert L. Hamill, James A. Mabe, David F. Mahoney, Walter M. Nakatsukasa, Raymond C. Yao
  • A80407 antibiotics
    Patent number: 5213797
    Abstract: New glycopeptide antibiotic A80407, comprising A80407A and A80407B, is produced by Kibdelosporangium philippinensis strains NRRL 18198, and NRRL 18199 or A80407-producing mutants of these strains. The A80407 antibiotics have excellent activity against Gram-positive bacteria, increase feed-utilization efficiency in monogastric and ruminant animals and improve weight gains in animals.
    Type: Grant
    Filed: December 11, 1990
    Date of Patent: May 25, 1993
    Assignee: Eli Lilly and Company
    Inventors: Lawrence E. Doolin, Richard M. Gale, Otis W. Godfrey, Robert L. Hamill, David F. Mahoney, Raymond C. Yao
  • A80407 antibiotics
    Patent number: 4996148
    Abstract: New glycopeptide antibiotic A80407, comprising A80407A and A80407B, is produced by Kibdelosporangium philippinensis strains NRRL 18198, and NRRL 18199 or A80407-producing mutants of these strains. The A80407 antibiotics have excellent activity against Gram-positive bacteria, increase feed-utilization efficiency in monogastric and ruminant animals and improve weight gains in animals.
    Type: Grant
    Filed: July 13, 1987
    Date of Patent: February 26, 1991
    Assignee: Eli Lilly and Company
    Inventors: Lawrence E. Doolin, Richard M. Gale, Otis W. Godfrey, Robert L. Hamill, David F. Mahoney, Raymond C. Yao
  • Babesiosis vaccine prepared from soluble parasitic antigen factors isolated from disintegration of Babesia infected erythrocites
    Patent number: 4457915
    Abstract: This invention relates to a method of preparation of a babesiosis vaccine which involves treating a suspension of Babesia infected erythrocytes. The erythrocytes are disintegrated, separated into soluble and insoluble fractions and subsequently fibrinogen and contaminated Babesia antigen is removed from the soluble fraction. The residual soluble fraction is then combined with an adjuvant to form the babesiosis vaccine. The invention also includes within its scope a vaccine derived from the abovementioned method and a method of administration of the vaccine to cattle.
    Type: Grant
    Filed: October 15, 1982
    Date of Patent: July 3, 1984
    Inventors: Brian V. Goodger, David F. Mahoney, Ian G. Wright